Global Heart Failure Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 29-Nov-2018
No. of pages: 135

The global heart failure drugs market is generic in nature; as many generic drug manufacturers and pharmaceutical giants are providing drugs for a disease. However; the arrival of innovative drugs such as EOM, is expected to change the market dynamics. AstraZeneca and Novartis hold the major share of the global heart failure drugs market with their drugs Toprol-XL and wog, respectively. The companies also hold a strong pipeline and are expected to remain the market leaders during the forecast period. Based on the drug class the market can be segmented into Beta blockers, ARBs, and ACE inhibitors. Angiotensin II receptor blockers (ARB) are a group of pharmaceuticals that modify the renin-angiotensin system. The heart disease drugs market is experiencing growth in the ARBs segment because it reduces the risk of death caused by heart failure and minimizes the chance of hospitalization of people with heart failure.

Scope of the Report:

This report focuses on the Heart Failure Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The latest trend gaining momentum in the market is investment inclination toward developing countries. Countries such as India, China, and Brazil are turning out to be some of the most attractive countries for pharmaceutical companies across the globe. Many factors such as huge share of global population and rising geriatric population are leading to the high growth of healthcare sector in the developing countries. In addition, the rising cases of lifestyle disorders such as obesity and diabetes also contribute to higher heart failure cases in the region.

One of the major drivers for this market is rising geriatric population. A large number of health problems are associated with the rising age, and CVDs are major among them. As a person gets older, the blood vessels become less flexible, thus making it difficult for the blood to flow through them. Rising age accompanied by other factors such as lifestyle-oriented diseases and smoking increases the risk of CVDs, especially heart failure. Heart failure in the geriatric population will continue to be a rising health burden globally, as this population represents the majority of the heart failure patients. Hence, rising geriatric population drives the demand for heart failure drugs during the forecast period.

The worldwide market for Heart Failure Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Amgen

- AstraZeneca

- Bayer

- Novartis

- Gilead

- GlaxoSmithKline

- Pfizer

- Teva Pharmaceutical industries

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Beta Blockers

- ARBs

- ACE Inhibitors

Market Segment by Applications, can be divided into

- Hospital

- Pharmacy

- Others

There are 15 Chapters to deeply display the global Heart Failure Drugs market.

Chapter 1, to describe Heart Failure Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Heart Failure Drugs, with sales, revenue, and price of Heart Failure Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Heart Failure Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Heart Failure Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Heart Failure Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Heart Failure Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Heart Failure Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Beta Blockers
1.2.2 ARBs
1.2.3 ACE Inhibitors
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Pharmacy
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Heart Failure Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 AstraZeneca
2.2.1 Business Overview
2.2.2 Heart Failure Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Heart Failure Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Heart Failure Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Gilead
2.5.1 Business Overview
2.5.2 Heart Failure Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Gilead Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 GlaxoSmithKline
2.6.1 Business Overview
2.6.2 Heart Failure Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GlaxoSmithKline Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Heart Failure Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Teva Pharmaceutical industries
2.8.1 Business Overview
2.8.2 Heart Failure Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Pharmaceutical industries Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Heart Failure Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Heart Failure Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Heart Failure Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Heart Failure Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Heart Failure Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Heart Failure Drugs Market Analysis by Regions
4.1 Global Heart Failure Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Heart Failure Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Heart Failure Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Heart Failure Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Heart Failure Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Heart Failure Drugs Sales and Growth Rate (2013-2018)
4.5 South America Heart Failure Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Heart Failure Drugs Sales and Growth Rate (2013-2018)
5 North America Heart Failure Drugs by Countries
5.1 North America Heart Failure Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Heart Failure Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Heart Failure Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Heart Failure Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Heart Failure Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Heart Failure Drugs Sales and Growth Rate (2013-2018)
6 Europe Heart Failure Drugs by Countries
6.1 Europe Heart Failure Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Heart Failure Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Heart Failure Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Heart Failure Drugs Sales and Growth Rate (2013-2018)
6.3 UK Heart Failure Drugs Sales and Growth Rate (2013-2018)
6.4 France Heart Failure Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Heart Failure Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Heart Failure Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Heart Failure Drugs by Countries
7.1 Asia-Pacific Heart Failure Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Heart Failure Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Heart Failure Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Heart Failure Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Heart Failure Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Heart Failure Drugs Sales and Growth Rate (2013-2018)
7.5 India Heart Failure Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Heart Failure Drugs Sales and Growth Rate (2013-2018)
8 South America Heart Failure Drugs by Countries
8.1 South America Heart Failure Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Heart Failure Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Heart Failure Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Heart Failure Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Heart Failure Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Heart Failure Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Heart Failure Drugs by Countries
9.1 Middle East and Africa Heart Failure Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Heart Failure Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Heart Failure Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Heart Failure Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Heart Failure Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Heart Failure Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Heart Failure Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Heart Failure Drugs Sales and Growth Rate (2013-2018)
10 Global Heart Failure Drugs Market Segment by Type
10.1 Global Heart Failure Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Heart Failure Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Heart Failure Drugs Revenue and Market Share by Type (2013-2018)
10.2 Beta Blockers Sales Growth and Price
10.2.1 Global Beta Blockers Sales Growth (2013-2018)
10.2.2 Global Beta Blockers Price (2013-2018)
10.3 ARBs Sales Growth and Price
10.3.1 Global ARBs Sales Growth (2013-2018)
10.3.2 Global ARBs Price (2013-2018)
10.4 ACE Inhibitors Sales Growth and Price
10.4.1 Global ACE Inhibitors Sales Growth (2013-2018)
10.4.2 Global ACE Inhibitors Price (2013-2018)
11 Global Heart Failure Drugs Market Segment by Application
11.1 Global Heart Failure Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Pharmacy Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Heart Failure Drugs Market Forecast (2018-2023)
12.1 Global Heart Failure Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Heart Failure Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Heart Failure Drugs Market Forecast (2018-2023)
12.2.2 Europe Heart Failure Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Heart Failure Drugs Market Forecast (2018-2023)
12.2.4 South America Heart Failure Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Heart Failure Drugs Market Forecast (2018-2023)
12.3 Heart Failure Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Heart Failure Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Heart Failure Drugs Market Share Forecast by Type (2018-2023)
12.4 Heart Failure Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Heart Failure Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Heart Failure Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Heart Failure Drugs Picture
Table Product Specifications of Heart Failure Drugs
Figure Global Sales Market Share of Heart Failure Drugs by Types in 2017
Table Heart Failure Drugs Types for Major Manufacturers
Figure Beta Blockers Picture
Figure ARBs Picture
Figure ACE Inhibitors Picture
Figure Heart Failure Drugs Sales Market Share by Applications in 2017
Figure Hospital Picture
Figure Pharmacy Picture
Figure Others Picture
Figure United States Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Heart Failure Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Heart Failure Drugs Type and Applications
Table Amgen Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Heart Failure Drugs Type and Applications
Table AstraZeneca Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Heart Failure Drugs Type and Applications
Table Bayer Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Heart Failure Drugs Type and Applications
Table Novartis Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Gilead Basic Information, Manufacturing Base and Competitors
Table Gilead Heart Failure Drugs Type and Applications
Table Gilead Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Heart Failure Drugs Type and Applications
Table GlaxoSmithKline Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Heart Failure Drugs Type and Applications
Table Pfizer Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical industries Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical industries Heart Failure Drugs Type and Applications
Table Teva Pharmaceutical industries Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Heart Failure Drugs Sales by Manufacturer (2016-2017)
Figure Global Heart Failure Drugs Sales Market Share by Manufacturer in 2016
Figure Global Heart Failure Drugs Sales Market Share by Manufacturer in 2017
Table Global Heart Failure Drugs Revenue by Manufacturer (2016-2017)
Figure Global Heart Failure Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Heart Failure Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Heart Failure Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Heart Failure Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Global Heart Failure Drugs Revenue and Growth Rate (2013-2018)
Table Global Heart Failure Drugs Sales by Regions (2013-2018)
Table Global Heart Failure Drugs Sales Market Share by Regions (2013-2018)
Table Global Heart Failure Drugs Revenue by Regions (2013-2018)
Figure Global Heart Failure Drugs Revenue Market Share by Regions in 2013
Figure Global Heart Failure Drugs Revenue Market Share by Regions in 2017
Figure North America Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Europe Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure South America Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure North America Heart Failure Drugs Revenue and Growth Rate (2013-2018)
Table North America Heart Failure Drugs Sales by Countries (2013-2018)
Table North America Heart Failure Drugs Sales Market Share by Countries (2013-2018)
Figure North America Heart Failure Drugs Sales Market Share by Countries in 2013
Figure North America Heart Failure Drugs Sales Market Share by Countries in 2017
Table North America Heart Failure Drugs Revenue by Countries (2013-2018)
Table North America Heart Failure Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Heart Failure Drugs Revenue Market Share by Countries in 2013
Figure North America Heart Failure Drugs Revenue Market Share by Countries in 2017
Figure United States Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Canada Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Europe Heart Failure Drugs Revenue and Growth Rate (2013-2018)
Table Europe Heart Failure Drugs Sales by Countries (2013-2018)
Table Europe Heart Failure Drugs Sales Market Share by Countries (2013-2018)
Table Europe Heart Failure Drugs Revenue by Countries (2013-2018)
Figure Europe Heart Failure Drugs Revenue Market Share by Countries in 2016
Figure Europe Heart Failure Drugs Revenue Market Share by Countries in 2017
Figure Germany Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure UK Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure France Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Russia Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Italy Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Heart Failure Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Heart Failure Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Heart Failure Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Heart Failure Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Heart Failure Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Heart Failure Drugs Revenue Market Share by Countries 2017
Figure China Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Japan Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Korea Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure India Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure South America Heart Failure Drugs Revenue and Growth Rate (2013-2018)
Table South America Heart Failure Drugs Sales by Countries (2013-2018)
Table South America Heart Failure Drugs Sales Market Share by Countries (2013-2018)
Figure South America Heart Failure Drugs Sales Market Share by Countries in 2017
Table South America Heart Failure Drugs Revenue by Countries (2013-2018)
Table South America Heart Failure Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Heart Failure Drugs Revenue Market Share by Countries in 2017
Figure Brazil Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Heart Failure Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Heart Failure Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Heart Failure Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Heart Failure Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Heart Failure Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Heart Failure Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Heart Failure Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Heart Failure Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure UAE Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Heart Failure Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Heart Failure Drugs Sales and Growth Rate (2013-2018)
Table Global Heart Failure Drugs Sales by Type (2013-2018)
Table Global Heart Failure Drugs Sales Share by Type (2013-2018)
Table Global Heart Failure Drugs Revenue by Type (2013-2018)
Table Global Heart Failure Drugs Revenue Share by Type (2013-2018)
Figure Global Beta Blockers Sales Growth (2013-2018)
Figure Global Beta Blockers Price (2013-2018)
Figure Global ARBs Sales Growth (2013-2018)
Figure Global ARBs Price (2013-2018)
Figure Global ACE Inhibitors Sales Growth (2013-2018)
Figure Global ACE Inhibitors Price (2013-2018)
Table Global Heart Failure Drugs Sales by Application (2013-2018)
Table Global Heart Failure Drugs Sales Share by Application (2013-2018)
Figure Global Pharmacy Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Heart Failure Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Heart Failure Drugs Sales Forecast by Regions (2018-2023)
Table Global Heart Failure Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Heart Failure Drugs Market Forecast (2018-2023)
Figure Europe Sales Heart Failure Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Heart Failure Drugs Market Forecast (2018-2023)
Figure South America Sales Heart Failure Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Heart Failure Drugs Market Forecast (2018-2023)
Table Global Heart Failure Drugs Sales Forecast by Type (2018-2023)
Table Global Heart Failure Drugs Market Share Forecast by Type (2018-2023)
Table Global Heart Failure Drugs Sales Forecast by Application (2018-2023)
Table Global Heart Failure Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global and Chinese Myocardial Infarction Drugs Industry, 2018 Market Research Report
    Published: 10-Dec-2018        Price: US 3000 Onwards        Pages: 136
    The 'Global and Chinese Myocardial Infarction Drugs Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Myocardial Infarction Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Myocardial Infarction Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview......
  • Global and Chinese Rosuvastatin Industry, 2018 Market Research Report
    Published: 10-Dec-2018        Price: US 3000 Onwards        Pages: 150
    The 'Global and Chinese Rosuvastatin Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Rosuvastatin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Rosuvastatin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, ap......
  • Global and Chinese Rosuvastatin Calcium Industry, 2018 Market Research Report
    Published: 09-Dec-2018        Price: US 3000 Onwards        Pages: 139
    The 'Global and Chinese Rosuvastatin Calcium Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Rosuvastatin Calcium industry with a focus on the Chinese market. The report provides key statistics on the market status of the Rosuvastatin Calcium manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry incl......
  • Global and Chinese Atorvastatin Calcium Industry, 2018 Market Research Report
    Published: 09-Dec-2018        Price: US 3000 Onwards        Pages: 149
    The 'Global and Chinese Atorvastatin Calcium Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Atorvastatin Calcium industry with a focus on the Chinese market. The report provides key statistics on the market status of the Atorvastatin Calcium manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry incl......
  • Global Myocardial Ischemia Drugs Market Insights, Forecast to 2025
    Published: 04-Dec-2018        Price: US 3900 Onwards        Pages: 117
    In 2017, the global Myocardial Ischemia Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Myocardial Ischemia Drugs market based on company, product type, application and key regions. This report studies the global market size of Myocardial Ischemia Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle E......
  • Investigation Report on China’s Rosuvastatin Market, 2018-2022
    Published: 29-Nov-2018        Price: US 2200 Onwards        Pages: 30
    Rosuvastatin was first developed by Japanese company Shionogi & Co., Ltd. in the late 1980s. In Jun. 1998, Shionogi & Co., Ltd. transferred the right to develop, market and sell Rosuvastatin worldwide to AstraZeneca. The development code of Rosuvastatin by AstraZeneca is ZD-4522. Rosuvastatin was first approved in the Netherlands on Nov. 7, 2002, approved by the Health Council of Canada in Feb. 2003, and by the FDA on Aug. 12, 2003. The trade name of Astra......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Heart Failure Drugs Market 2018, Forecast to 2023
    Published: 29-Nov-2018        Price: US 4880 Onwards        Pages: 137
    The global heart failure drugs market is generic in nature; as many generic drug manufacturers and pharmaceutical giants are providing drugs for a disease. However; the arrival of innovative drugs such as EOM, is expected to change the market dynamics. AstraZeneca and Novartis hold the major share of the global heart failure drugs market with their drugs Toprol-XL and wog, respectively. The companies also hold a strong pipeline and are expected to remain the market leaders during the forecast pe......
  • Global Simvastatin Market Data Survey Report 2025
    Published: 27-Nov-2018        Price: US 1500 Onwards        Pages: 69
    Summary The global Simvastatin market will reach Volume Million USD in 2018 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capacity and prod......
  • Global and Chinese Atorvastatin Industry, 2018 Market Research Report
    Published: 24-Nov-2018        Price: US 3000 Onwards        Pages: 142
    The 'Global and Chinese Atorvastatin Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Atorvastatin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Atorvastatin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, ap......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs